Stratigos, A. J., Sekulic, A., Peris, K., Bechter, O., Prey, S., Kaatz, M., Lewis, K. D., Basset-Seguin, N., Chang, A. L. S., Dalle, S., Orland, A. F., Licitra, L., Robert, C., Ulrich, C., Hauschild, A., Migden, M. R., Dummer, R., Yoo, S.-Y., Coates, E., Okoye, E., Bassukas, I., Loquai, C., De Giorgi, V., Eroglu, Z., Gutzmer, R., Ulrich, J., Puig, S., Seebach, F., Lowy, I. and Fury, M. G. (2023) “Phase 2 study of cemiplimab in patients with locally advanced basal cell carcinoma after hedgehog inhibitor therapy: Long-term follow-up”, SKIN The Journal of Cutaneous Medicine, 7(2), p. s178. doi: 10.25251/skin.7.supp.178.